##{"id":98444,"date":"2021-12-03T17:24:00","date_gmt":"2021-12-03T06:24:00","guid":{"rendered":"https:\/\/www.fnarena.com\/index.php\/2021\/12\/03\/starpharma-signs-distribution-agreement-for-viraleze-antiviral-nasal-spray-in-vietnam\/"},"modified":"2021-12-03T17:24:00","modified_gmt":"2021-12-03T06:24:00","slug":"starpharma-signs-distribution-agreement-for-viraleze-antiviral-nasal-spray-in-vietnam","status":"publish","type":"post","link":"https:\/\/staging.fnarena.com\/index.php\/2021\/12\/03\/starpharma-signs-distribution-agreement-for-viraleze-antiviral-nasal-spray-in-vietnam\/","title":{"rendered":"Starpharma signs distribution agreement for VIRALEZE\u2122 antiviral nasal spray in Vietnam"},"content":{"rendered":"<ul type=\"disc\">\n<li><b>Starpharma has signed a 5-year supply and distribution agreement for VIRALEZE\u2122 in <span class=\"xn-location\">Vietnam<\/span><\/b> <\/li>\n<li><b>The agreement includes <\/b><b>a minimum commitment of 1 million units in the first year <\/b><\/li>\n<li><b>VIRALEZE\u2122 is scheduled to be officially launched in <span class=\"xn-location\">Vietnam<\/span> today, following its registration for sale this week<\/b> <\/li>\n<li><b>VIRALEZE\u2122 is a broad-spectrum antiviral nasal spray that contains SPL7013, which has been shown to have potent antiviral and virucidal activity in multiple respiratory viruses, including inactivation of &#062;99.9% of the Delta variant of SARS-CoV-2, in laboratory studies that have been published in international, peer reviewed journals<\/b><\/li>\n<\/ul>\n<p><span class=\"xn-location\">MELBOURNE, Australia<\/span>, <span class=\"xn-chron\">Dec. 3, 2021<\/span> \/PRNewswire\/ &#8212; Australian biotech company&#160;<a target=\"_blank\" href=\"https:\/\/starpharma.com\/\" rel=\"nofollow\">Starpharma<\/a>&#160;has signed a 5-year supply and distribution arrangement for its VIRALEZE\u2122 antiviral nasal spray in <span class=\"xn-location\">Vietnam<\/span>, with a minimum commitment of 1 million units in the first year. <\/p>\n<p>The official launch of VIRALEZE\u2122 in <span class=\"xn-location\">Vietnam<\/span> is scheduled to occur today and will be attended by key health officials, healthcare leaders, and media.<\/p>\n<p><span class=\"xn-location\">Vietnam<\/span>, which has a population of approximately 98 million, is experiencing a significant Delta outbreak with just over half of its population vaccinated.<\/p>\n<p>VIRALEZE\u2122 will be available in <span class=\"xn-location\">Vietnam<\/span> to retail consumers, clinics, hospitals, and pharmacies through the local medical distribution networks in <span class=\"xn-location\">Vietnam<\/span>. <\/p>\n<p>VIRALEZE\u2122 is a broad-spectrum antiviral nasal spray. The antiviral agent in VIRALEZE\u2122, referred to as SPL7013, has been shown in laboratory studies to have potent antiviral and virucidal activity in multiple respiratory\/cold viruses. Further, SPL7013 has been shown in laboratory studies to inactivate multiple variants of SARS-CoV-2 (the virus that causes COVID-19), including inactivation of &#062;99.9% of the highly infectious Delta variant. <\/p>\n<p>VIRALEZE\u2122 is applied in the nose to provide a physical barrier &#8211; between viruses and the nasal mucous membrane &#8211; that traps and irreversibly inactivates virus. <\/p>\n<p>Importantly, VIRALEZE\u2122 has a mechanism of action that is not adversely impacted by mutations in the spike proteins that make SARS-CoV-2 more infectious, as occurred with the Delta strain, which appears to make the virus more susceptible to trapping and blocking by SPL7013.<\/p>\n<p>Dr <span class=\"xn-person\">Jackie Fairley<\/span>, Starpharma CEO commented: &#034;We are delighted to see our partners launch VIRALEZE\u2122 in <span class=\"xn-location\">Vietnam<\/span> so rapidly, particularly given the current Delta outbreak across the country.&#160;In parallel, Starpharma continues to advance its discussions with potential commercial partners elsewhere in multiple countries in <span class=\"xn-location\">Europe<\/span>, <span class=\"xn-location\">Asia<\/span>, the <span class=\"xn-location\">Middle East<\/span>, and <span class=\"xn-location\">India<\/span>.&#034;<\/p>\n<p>VIRALEZE\u2122 is also available in certain markets at <a target=\"_blank\" href=\"http:\/\/www.viraleze.co\/\" rel=\"nofollow\">www.Viraleze.co<\/a>. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Starpharma has signed a 5-year supply and distribution agreement for VIRALEZE\u2122 in Vietnam The agreement includes a minimum commitment of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[105],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/98444"}],"collection":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/comments?post=98444"}],"version-history":[{"count":0,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/98444\/revisions"}],"wp:attachment":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media?parent=98444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/categories?post=98444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/tags?post=98444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}